AGTC > up 123% today on positive XLRP data... AGTC Reports Positive Six-Month Data from its Ongoing Phase 1/2 Clinical Trial in X-Linked Retinitis Pigmentosa http://ir.agtc.com/news-releases/news-release-details/agtc-reports-positive-six-month-data-its-ongoing-phase-12